SELECT LANGUAGE BELOW

FDA approves first medication for obstructive sleep apnea, promotes weight loss

The first treatment for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On December 20, the FDA announced that it has approved Eli Lilly's Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults. The FDA noted that the drug should be combined […]